CN112698020B - Multimodal coupling analysis method of cross response system based on DNA-AuNP coding - Google Patents
Multimodal coupling analysis method of cross response system based on DNA-AuNP coding Download PDFInfo
- Publication number
- CN112698020B CN112698020B CN202011264226.4A CN202011264226A CN112698020B CN 112698020 B CN112698020 B CN 112698020B CN 202011264226 A CN202011264226 A CN 202011264226A CN 112698020 B CN112698020 B CN 112698020B
- Authority
- CN
- China
- Prior art keywords
- dna
- gold nanoparticles
- polya
- aunps
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000004044 response Effects 0.000 title claims abstract description 32
- 238000004458 analytical method Methods 0.000 title claims abstract description 24
- 230000008878 coupling Effects 0.000 title claims abstract description 18
- 238000010168 coupling process Methods 0.000 title claims abstract description 18
- 238000005859 coupling reaction Methods 0.000 title claims abstract description 18
- 239000002105 nanoparticle Substances 0.000 claims abstract description 74
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000010931 gold Substances 0.000 claims abstract description 60
- 229910052737 gold Inorganic materials 0.000 claims abstract description 60
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 47
- 230000002776 aggregation Effects 0.000 claims abstract description 26
- 238000004220 aggregation Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000003298 DNA probe Substances 0.000 claims abstract description 17
- 150000002343 gold Chemical class 0.000 claims abstract description 12
- 210000001124 body fluid Anatomy 0.000 claims abstract description 11
- 239000010839 body fluid Substances 0.000 claims abstract description 11
- 238000010276 construction Methods 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims description 25
- 238000000862 absorption spectrum Methods 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 238000010586 diagram Methods 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 9
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 6
- 238000012512 characterization method Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 210000003296 saliva Anatomy 0.000 claims description 6
- 210000004243 sweat Anatomy 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- IKRZCYCTPYDXML-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;hydrochloride Chemical compound Cl.OC(=O)CC(O)(C(O)=O)CC(O)=O IKRZCYCTPYDXML-UHFFFAOYSA-N 0.000 claims description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
- 229930024421 Adenine Natural products 0.000 claims description 3
- 229910004042 HAuCl4 Inorganic materials 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 229960000643 adenine Drugs 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 2
- 229940038773 trisodium citrate Drugs 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 16
- 230000008569 process Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000002902 bimodal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Electrochemistry (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention belongs to the field of biomedical sensing detection, and particularly relates to a multimodal coupling analysis method of a cross-response sensing system based on DNA-AuNP coding, which comprises the following steps: modifying the gold nanoparticles by polyA-DNA probes with different lengths to obtain various DNA-AuNPs with different binding capacities of the polyA-DNA and the surfaces of the gold nanoparticles, and completing the construction of the cross response sensor taking the aggregation degree of the polyA-DNA modified gold nanoparticles with different lengths as a variation factor; obtaining fingerprint information of aggregation degrees of different types of gold nanoparticles induced by the object to be detected by coupling multimodal signals; and classifying and identifying different types of objects to be detected according to the fingerprint information. The invention can solve the technical problems of complicated biochemical detection and classification process, strong specialization, high cost and easy interference of the existing metal ions, and provides an analysis method with convenient detection, time saving, non-specificity and high sensitivity. The invention can also detect and compare the fingerprint information obtained by the body fluids of the normal person and the patient, construct an aggregation degree database and hopefully improve the distinction between the normal person and the patient.
Description
Technical Field
The invention belongs to the field of biomedical sensing detection, and particularly relates to a multimodal coupling analysis method of a cross response system based on DNA-AuNP coding.
Background
The gold nanoparticle compound is widely applied to the field of biomedical sensing detection, but most of the existing characterization methods only consider the single modal characteristic of a single gold nanoparticle compound reaction caused by a detection object, and ignore the complementary advantages among different modal characteristics; meanwhile, in the data processing process, the same weight is usually given to all data, wherein the quality of the extracted features is affected by the information of weak correlation, so that the detection of the detected object with high precision and high sensitivity cannot be realized.
For example: the current common gold nanoparticle composite analysis method comprises the following steps: ultraviolet spectrophotometry (UV), which utilizes electronic resonance on the surface of gold nanoparticles, and gathers gold nanoparticles to different degrees when an object to be detected interacts with modifiers on the surface of the gold nanoparticles, thereby obtaining ultraviolet absorption spectrum fingerprint data, wherein the single-mode analysis method has low accuracy and low detection efficiency due to the influence of the number of specific receptors; atomic Absorption Spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), Surface Enhanced Raman (SERS), electron microscopy (SEM, TEM), etc., have been greatly limited in their application due to the high cost and complex sample pretreatment. Based on these problems, it is important to develop a cross-response sensor that can analyze a plurality of signals quickly and has a simple detection means.
Disclosure of Invention
The invention provides a multimodal coupling analysis method of a cross response system based on DNA-AuNP coding, which can realize high-precision and high-sensitivity classification of various objects to be detected, and aims to overcome the problem that the existing detection method can not realize high-precision and high-sensitivity detection.
In order to solve the technical problems, the technical scheme of the invention is as follows: a multimodal coupling analysis method based on a cross-response system encoded by DNA-AuNP, said method comprising the steps of:
modifying the gold nanoparticles by using polyA-DNA probes with different lengths to obtain various DNA-AuNPs with different binding capacities of the polyA-DNA and the gold nanoparticles, wherein the different DNA-AuNPs have different aggregation degrees on a substance to be detected; thus completing the construction of the cross-response sensor taking the aggregation degree of the polyA-DNA modified gold nanoparticles with different lengths as a change factor;
obtaining fingerprint information of aggregation degrees of different types of gold nanoparticles induced by the object to be detected by coupling multimodal signals; and classifying and identifying different types of objects to be detected according to the fingerprint information.
Preferably, the analyte inducing the gold nanoparticles to aggregate includes, but is not limited to, metal ions, bacteria, body fluids; wherein,the metal ions include but are not limited to: ca 2+ 、Cu 2+ 、Fe 3+ 、Mg 2+ 、Zn 2+ (ii) a The body fluid includes but is not limited to cerebrospinal fluid, saliva, urine, sweat.
Further, the degree of aggregation of gold nanoparticles gives rise to a multimodal signal by a variety of characterization means including, but not limited to: ultraviolet absorption spectrum, surface zeta potential and particle size.
Further, the adenine base numbers of the polyA-DNA probe are respectively: 5. 10, 20, 30, 40, 50.
And further, classifying and identifying the obtained fingerprint data by adopting a linear discriminant analysis algorithm.
Further, modifying the gold nanoparticles by using a polyA-DNA probe, which comprises the following steps:
mixing polyA-DNA with the volume of 1uL and the concentration of 100uM with gold nanoparticle solution with the volume of 10uL and the concentration of 100nM, adding Citrate-HCl with the volume of 0.2uL, the concentration of 500mM and the pH of 3, and incubating for 10 minutes at room temperature; and (3) removing the supernatant through centrifugation, adding the supernatant into PBS buffer solution with the volume of 100uL, the concentration of 10mM and the pH of 7, repeating for many times, removing redundant polyA-DNA chains, and finishing modification of the gold nanoparticles by the polyA-DNA probe, wherein the obtained solution is the DNA functionalized gold nanoparticles with the concentration of 10 nM.
Still further, the rotation speed of centrifugation is 14000rpm, and the centrifugation time is 20 min.
Further, a cross-response sensor using the aggregation degree of the polyA-DNA modified gold nanoparticles with different lengths as a variation factor is constructed, and the cross-response sensor is specifically as follows:
adding 10uL of polyA-DNA modified gold nanoparticle solution into metal cation solutions with different concentrations and a volume of 90uL to ensure that the final concentration of the polyA-DNA modified gold nanoparticle solution in a reaction system is about 1nM, and carrying out a light-shielding reaction at room temperature;
after 3 hours, the corresponding absorption spectrum is recorded, and the response of the spectrum signal is represented by A/A 0 Obtaining wherein A and A 0 Are respectively ultravioletAbsorption, A/A 0 OD626nm/OD524 nm; and simultaneously recording zeta potential and particle size of the aggregated gold nanoparticles, thereby obtaining 'fingerprint' information of ultraviolet fluorescence absorption spectrum, particle size and zeta potential diagram of the DNA-AuNPs system in the presence of different types of metal ions.
Still further, in order to eliminate background interference, the ultraviolet absorption spectrum A/A of gold nanoparticles modified with polyA5-DNA in the absence of metal ions was measured 0 The resulting data of (a) is normalized.
Compared with the prior art, the technical scheme of the invention has the beneficial effects that:
the method can be used for accurately identifying various metal ions. The DNA-AuNP gold nanoparticles in the system can be aggregated in different degrees due to different concentrations and types of metal ions, and different signals are generated by the ultraviolet absorption spectrum, the surface potential and the particle size of the gold nanoparticles in the cross response sensor, so that the simultaneous high-precision detection and identification of multiple types of metal ions can be realized in a multimodal output signal mode.
The invention takes ultraviolet absorption spectrum, surface potential, particle size and polyA-DNA probes with different lengths as characteristic variable regulating and controlling factors, can meet the requirement of detecting various metal ions by increasing the dimensionality of the characteristic variables, obtains the big data of aggregation degree characteristic signals, and completes artificial intelligent mode recognition training operation and classification operation.
The invention can also detect and compare the fingerprint information obtained by the body fluids of the normal person and the patient, construct an aggregation degree database and hopefully improve the distinction between the normal person and the patient.
Drawings
FIG. 1 is the basic principle of the multimodal coupling analysis method of the DNA-AuNP-encoded cross-response sensor of the embodiment.
FIG. 2 is a diagram showing the preparation of DNA-AuNPs with different lengths and the multi-modal characterization of different aggregation degrees induced by different metal ions in this example.
Wherein, a) a DNA-attenuated coulombic self-assembly process; b) the AuNPs particle size detected by a Zetasizer Nano particle size analyzer and the characteristics of a Transmission Electron Microscope (TEM); c) ultraviolet absorption spectra of gold nanoparticles modified by polyA-DNA with different lengths; d) difference of ratio (A626/A524) of absorption spectra of polyA-DNA modified gold nanoparticles with different lengths; e) three different modalities, such as Abs; particle size; the surface zeta potential characterizes the aggregation behavior of 5 different DNA-AuNPs in the presence of different metal ions respectively.
FIG. 3 is the "fingerprint" information of the ultraviolet fluorescence absorption spectrum, particle size, zeta potential diagram of the aggregation degree of the gold nanoparticles of A5-AuNPs induced by five different metal ions in this example.
FIG. 4 is a classification diagram and a comparison diagram of identification accuracy of 5 different metal ions by controlling different types of DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs and A50-AuNPs) and numbers under the output of single-mode signals of ultraviolet absorption spectrum (UV-VIS) of the DNA-AuNP-encoded cross-response sensor constructed in this embodiment.
Fig. 5 is a classification diagram and a comparison diagram of identification accuracy of 5 different metal ions by controlling different types of DNA-AuNPs (e.g., a5-AuNPs, a10-AuNPs, a20-AuNPs, a30-AuNPs, a40-AuNPs, and a50-AuNPs) and numbers of the DNA-AuNPs encoded cross-response sensor constructed in this example under the output of a particle size (DLS) single-mode signal.
FIG. 6 is a classification chart and identification accuracy comparison chart of 5 different metal ions by controlling different types of DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs and A50-AuNPs) and numbers under the surface zeta potential (zeta potential chart) single-mode signal output of the DNA-AuNP coding cross-response sensor constructed in this example.
FIG. 7 is a classification chart and a comparison chart of recognition accuracy of the DNA-AuNP-encoded cross-response sensor constructed in the present example for 5 different metal ions under ultraviolet absorption spectroscopy (UV-VIS) -particle size (DLS) bimodal signal output and the participation of 6 DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs, and A50-AuNPs).
FIG. 8 is a classification chart and a comparison chart of identification accuracy of 5 different metal ions by 6 DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs and A50-AuNPs) under the output of ultraviolet absorption spectrum (UV-VIS) -surface zeta potential (zeta potential chart) bimodal signals constructed in this example.
FIG. 9 is a classification chart and a comparison chart of identification accuracy of 5 different metal ions by 6 DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs and A50-AuNPs) under the bimodal signal output of particle size (DLS) -surface zeta potential (zeta potential chart) constructed in this example.
FIG. 10 is a classification chart and a comparison chart of identification accuracy of 5 different metal ions by the DNA-AuNP-encoded cross-response sensor constructed in this example under the output of ultraviolet absorption spectrum (UV-VIS) -particle size (DLS) -surface zeta potential (zeta potential chart) tri-modal signals and with the participation of 6 DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs, A50-AuNPs).
FIG. 11 is a classification chart of 5 different metal ions in cerebrospinal fluid, saliva, urine and sweat in 6 DNA-AuNPs (such as A5-AuNPs, A10-AuNPs, A20-AuNPs, A30-AuNPs, A40-AuNPs and A50-AuNPs) under the output of ultraviolet absorption spectrum (UV-VIS) -particle size (DLS) -surface zeta potential (zeta potential diagram) three-mode signals.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and are used for illustration only, and should not be construed as limiting the patent. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The technical solution of the present invention is further described below with reference to the accompanying drawings and examples.
Example 1
As shown in fig. 1 and fig. 2, a multimodal coupling analysis method based on a DNA-AuNP encoded cross response system comprises the following steps:
modifying the gold nanoparticles by using polyA-DNA probes with different lengths to obtain various DNA-AuNPs with different binding capacities of the polyA-DNA and the gold nanoparticles, wherein the different DNA-AuNPs have different aggregation degrees on a substance to be detected; thus completing the construction of the cross-response sensor taking the aggregation degree of the polyA-DNA modified gold nanoparticles with different lengths as a change factor;
obtaining fingerprint information of aggregation degrees of different types of gold nanoparticles induced by the object to be detected by coupling multimodal signals; and classifying and identifying different types of objects to be detected according to the fingerprint information.
The analyte inducing the gold nanoparticles to aggregate comprises but is not limited to metal ions, bacteria and body fluid; wherein, the metal ions include but are not limited to: ca 2+ 、Cu 2+ 、Fe 3+ 、Mg 2+ 、Zn 2+ (ii) a The body fluid includes but is not limited to cerebrospinal fluid, saliva, urine, sweat.
In the embodiment, the gold nanoparticles are modified by adopting the polyA-DNA probes with different lengths, and different induction factors enable DNA with different lengths to generate competitive reaction with the gold nanoparticles, so that DNA with different lengths can be separated from the surface of the gold nanoparticles to different degrees, thereby inducing the gold nanoparticles to gather, and fingerprint information can be obtained by coupling DNA with different lengths and outputting three signals. Different DNA-AuNPs have different aggregation degrees on metal ions, and according to the characteristics, the method can classify and identify the metal ions and can detect bacteria and body fluid. Any factor that can induce aggregation of gold nanoparticles can be detected using the method described in this example. In this embodiment, the method is described in detail by using gold nanoparticles with a particle size of 13nm, wherein the step of synthesizing the gold nanoparticles with a particle size of 13nm specifically comprises the following steps:
1% trisodium citrate (3.5mL) was added to a boiling and rapidly stirring aqueous solution of HAuCl4(100mL, 0.01%), the solution was kept boiling for 20 minutes, then cooled to room temperature to obtain a gold nanoparticle solution, which was stored at 4 ℃ until use.
In a specific embodiment, the number of bases adenine (A) of the polyA-DNA probe is: 5. 10, 20, 30, 40, 50. The polyA-DNA probe sequences used for modification were as follows:
in a specific example, gold nanoparticles modified with polyA-DNA probes were as follows: mixing polyA-DNA with a volume of 1uL and a concentration of 100uM with a gold nanoparticle solution with a volume of 10uL and a concentration of 100nM, adding Citrate-HCl with a volume of 0.2uL, a concentration of 500mM and a pH of 3, and incubating at room temperature for 10 minutes; the supernatant was removed by centrifugation, and added to PBS buffer solution with a volume of 100uL, a concentration of 10mM, and a pH of 7, and repeated several times to remove excess polyA-DNA strands, thereby completing modification of gold nanoparticles with polyA-DNA probe, and the obtained solution was DNA functionalized gold nanoparticles with a concentration of 10nM, which was defined as DNA-AuNP in this example. The rotation speed adopted by the centrifugation is 14000rpm, and the centrifugation time is 20 min.
In a specific embodiment, the metal ion is used as a factor for inducing aggregation of DNA-AuNP, and the metal ions used in this embodiment include, but are not limited to: ca 2+ 、Cu 2+ 、Fe 3+ 、Mg 2+ 、Zn 2+ 。
In a specific embodiment, the degree of aggregation of the gold nanoparticles is obtained by a number of characterization means including, but not limited to: ultraviolet absorption spectrum, surface zeta potential and particle size.
In a specific embodiment, a cross-response sensor with the aggregation degree of gold nanoparticles modified by polyA-DNA probes with different lengths as a change factor is constructed, and the specific steps are as follows: 10uL of the AuNPs solution modified by the polyA-DNA is added into metal cation solutions (90uL) with different concentrations, so that the final concentration of the AuNPs solution modified by the polyA-DNA in a reaction system is about 1nM, and the light-shielding reaction is carried out at room temperature. After 3 hours, use the microplate reader andthe uv-vis spectrophotometer records the corresponding absorption spectrum. The response of the spectral signal is represented by A/A 0 Obtaining wherein A and A 0 Respectively, ultraviolet absorption (a/a0 ═ OD626nm/OD524 nm). To eliminate background interference, the raw data were obtained by modifying AuNPs UV absorption Spectroscopy A/A with polyA5-DNA in the absence of metal ions 0 The results of (a) are normalized. At the same time, the zeta potential and the particle size of the aggregated nanoparticles were recorded using a Malvern nano-potentiostat ZS 90. Thus, the 'fingerprint data' information of the ultraviolet fluorescence absorption spectrum, the particle size and the zeta potential diagram of the DNA-AuNPs system in the presence of different metal ions is obtained. This example was performed in 8 replicate experiments for each metal ion.
In a specific embodiment, a Linear Discriminant Analysis (LDA) algorithm is used to realize high-precision classification of different types of metal ions according to the obtained "fingerprint data": the method can be specifically operated in the Rstudio, and specific codes are as follows:
setwd ("E:/test") # sets the test folder under D disk as the working folder, and puts in the data file in csv format, where it is
setwd("E:/test")
library(devtools)
library(ggord)
library(MASS)
library(ggplot2)
data<-read.csv("metal ions.csv",sep＝",",header＝T)
data$group<-as.factor(data$group)
model1＝lda(group～.,data＝data)
model1
plot(model1,dimen＝2)
ld<-predict(model1)$x
ord<-lda(group～.,data)
p < -ggord (ord, data group, arrow ═ 0, vec _ ext ═ 0, size ═ 5, txt ═ NULL, poly ═ FALSE, and coord _ fix ═ F) # drawing
p+theme(panel.grid＝element_blank())
The ultraviolet fluorescence absorption spectrum, the particle size and the fingerprint information of a zeta potential diagram of the DNA-AuNPs system in the presence of five metal ions are shown in figure 3.
In the embodiment, the controllable gold nanoparticles modified by the length of the polyA-DNA sequence are aggregated, and a multi-modal analysis mode recognition algorithm is adopted to achieve simple and high-speed accurate analysis. Compared with the prior traditional DNA-AuNP sensor, the method is limited by the number and the type of receptors. The method improves the condition that the quantity and the type of the recognition receptors are limited due to steric hindrance of the gold nanoparticles, reduces the complexity of a mode recognition algorithm by combining a multi-mode coupling analysis algorithm, and effectively improves the recognition accuracy of rapid detection and accurate analysis. And the method is used for detecting various metal ions, and the accuracy can reach 100%.
In addition, the detection object of the cross-response sensor has universality, and by designing different gold nanoparticles modified by polyA-DNA, rapid and ultrasensitive detection and analysis on different detection objects (including biological small molecules (such as metal ions and the like), biological macromolecules (such as DNA, miRNA, protein and the like), viruses, bacteria, cells and the like) can be realized.
To further illustrate the effect obtained by the method of this embodiment, the following is a demonstration of the classification effect of different metal ions as the number of modes increases, and as the result shows, the classification effect of metal ions becomes better and better as the number of modes increases. Therefore, the fingerprint information generated by different metal ions by adopting the linear discriminant analysis algorithm is practical and effective.
In a specific embodiment, since the body fluid contains metal ions, the method described in the above embodiment can realize accurate distinction of metal ions in different body fluids, specifically as follows:
dissolving metal ions into cerebrospinal fluid, saliva, urine and sweat, and then adding 10ul of polyA-DNA modified gold nanoparticle solution to make the final concentration of polyA-DNA modified gold nanoparticle solution in the reaction system about 1nM, and the final concentration of metal ions isCarrying out light-shielding reaction at room temperature at 1 mu M; after 3 hours, the corresponding absorption spectrum is recorded, and the response of the spectrum signal is represented by A/A 0 Obtaining wherein A and A 0 Respectively, is ultraviolet absorption, A/A 0 OD626nm/OD524 nm; and simultaneously recording zeta potential and particle size of the aggregated gold nanoparticles, thereby obtaining 'fingerprint' information of ultraviolet fluorescence absorption spectrum, particle size and zeta potential diagram of the DNA-AuNPs system in the presence of different types of metal ions. The results thus obtained are shown in fig. 11, from which it can be seen that the metal ion classification can be significantly improved by the method described in this example from fig. 11. Biological fluids including saliva, urine, sweat, and cerebrospinal fluid play an important role in human health. Biological fluids can be analyzed in medical laboratories for the discovery of microorganisms, inflammation, cancer, and the like. Medically, it is a specimen used in diagnostic examinations or evaluations and to determine a disease or condition.
It should be understood that the above-described embodiments of the present invention are merely examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention should be included in the protection scope of the claims of the present invention.
Claims (4)
1. A multimodal coupling analysis method based on a DNA-AuNP coding cross response system is characterized by comprising the following steps: the method comprises the following steps:
modifying the gold nanoparticles by using polyA-DNA probes with different lengths to obtain various DNA-AuNPs with different binding capacities of the polyA-DNA and the gold nanoparticles, wherein the different DNA-AuNPs have different aggregation degrees on a substance to be detected; thus completing the construction of the cross-response sensor taking the aggregation degree of the polyA-DNA modified gold nanoparticles with different lengths as a change factor;
obtaining fingerprint information of aggregation degrees of different types of gold nanoparticles induced by the object to be detected by coupling multimodal signals; classifying and identifying different types of objects to be detected according to the fingerprint information;
constructing a cross-response sensor taking the aggregation degree of the gold nanoparticles modified by polyA-DNA with different lengths as a variation factor, which comprises the following steps:
adding 10uL of polyA-DNA modified gold nanoparticle solution into metal cation solutions with different concentrations and a volume of 90uL to ensure that the final concentration of the polyA-DNA modified gold nanoparticle solution in a reaction system is 1nM, and carrying out light-shielding reaction at room temperature;
after 3 hours, the corresponding absorption spectrum is recorded, and the response of the spectrum signal is represented by A/A 0 Obtaining wherein A and A 0 Respectively, is UV absorption, A/A 0 = OD626nm/OD524 nm; simultaneously recording zeta potential and particle size of the gathered gold nanoparticles, thereby obtaining 'fingerprint' information of ultraviolet fluorescence absorption spectrum, particle size and zeta potential diagram of the DNA-AuNPs system in the presence of different kinds of metal ions;
inducing the gold nanoparticles to generate aggregated objects to be tested, including metal ions in body fluid; wherein, the metal ions include but are not limited to: ca 2+ 、Cu 2+ 、Fe 3+ 、Mg 2+ 、Zn 2+ (ii) a The body fluid includes but is not limited to cerebrospinal fluid, saliva, urine, sweat;
obtaining a multimodal signal through various characterization means according to the aggregation degree of the gold nanoparticles, wherein the characterization means is a combination of an ultraviolet absorption spectrum, a surface zeta potential and a particle size;
modifying the gold nanoparticles by adopting a polyA-DNA probe, which comprises the following steps:
mixing polyA-DNA with the volume of 1uL and the concentration of 100uM with a gold nanoparticle solution with the volume of 10uL and the concentration of 100nM, adding Citrate-HCl with the volume of 0.2uL, the concentration of 500mM and the pH =3, and incubating for 10 minutes at room temperature; removing supernatant through centrifugation, adding the supernatant into PBS buffer solution with the volume of 100uL, the concentration of 10mM and the pH =7, repeating for many times, removing redundant polyA-DNA chains, and finishing modification of gold nanoparticles by a polyA-DNA probe, wherein the obtained solution is DNA functionalized gold nanoparticles with the concentration of 10 nM;
the synthesis steps of the gold nanoparticles with the particle size of 13nm are as follows:
adding trisodium citrate with the concentration of 1% and the volume of 3.5mL into a boiling and rapidly-stirred HAuCl4 aqueous solution, wherein the volume of the HAuCl4 aqueous solution is 100mL and the concentration is 0.01%, keeping the solution boiling for 20 minutes, then cooling to room temperature to obtain a gold nanoparticle solution, and storing at 4 ℃ for later use;
and classifying and identifying the obtained fingerprint data by adopting a linear discriminant analysis algorithm.
2. The method of claim 1 for multimodal coupling analysis based on a cross-response system encoded by DNA-AuNP, characterized in that: the number of adenine bases of the polyA-DNA probe is respectively as follows: 5. 10, 20, 30, 40, 50.
3. The method of claim 2 for multimodal coupling analysis based on a DNA-AuNP coded cross response system, wherein: the rotation speed adopted by the centrifugation is 14000rpm, and the centrifugation time is 20 min.
4. The method of claim 3 for multimodal coupling analysis based on a DNA-AuNP-encoded cross-response system, wherein: to eliminate background interference, the ultraviolet absorption spectrum A/A of gold nanoparticles modified with polyA5-DNA in the absence of metal ions 0 The resulting data of (a) is normalized.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011264226.4A CN112698020B (en) | 2020-11-12 | 2020-11-12 | Multimodal coupling analysis method of cross response system based on DNA-AuNP coding |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011264226.4A CN112698020B (en) | 2020-11-12 | 2020-11-12 | Multimodal coupling analysis method of cross response system based on DNA-AuNP coding |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112698020A CN112698020A (en) | 2021-04-23 |
| CN112698020B true CN112698020B (en) | 2022-08-26 |
Family
ID=75507117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011264226.4A Active CN112698020B (en) | 2020-11-12 | 2020-11-12 | Multimodal coupling analysis method of cross response system based on DNA-AuNP coding |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112698020B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024141910A1 (en) * | 2022-12-30 | 2024-07-04 | Universita' Degli Studi Di Firenze | Raman active nanoparticle for sers spectroscopy, in particular for the detection of highly diluted analytes in liquid samples and related apparatus and method for sers spectroscopy |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102507551A (en) * | 2011-10-24 | 2012-06-20 | 国家纳米科学中心 | Reagents for detecting AChE (acetylcholinesterase) and preparation method thereof |
| CN103540651A (en) * | 2012-07-12 | 2014-01-29 | 中国科学院上海应用物理研究所 | Nanometer gold complex as well as preparation and application thereof |
| CN105334176A (en) * | 2015-11-30 | 2016-02-17 | 天津脉络生物科技有限公司 | Composition for AChE, method for screening AChE inhibitor and application |
| CN108359715A (en) * | 2018-02-06 | 2018-08-03 | 中国科学院上海高等研究院 | The controllable Nano-Au probe and its preparation and application that Poly A are mediated |
| CN108841923A (en) * | 2018-06-07 | 2018-11-20 | 南京邮电大学 | A kind of quantum dot based on DSN enzyme-magnetic bead miRNA sensor and preparation method thereof and detection method |
| CN109724970A (en) * | 2019-01-31 | 2019-05-07 | 华侨大学 | A method of based on gold nanoparticle colorimetric detection mercury ion |
| CN110530847A (en) * | 2019-09-26 | 2019-12-03 | 辽宁大学 | A kind of specific detection Cu2+Raman spectrum base and its preparation method and application |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503699A (en) * | 1999-06-25 | 2003-01-28 | ナノスフェアー インコーポレイテッド | Oligonucleotide-Attached Nanoparticles and Methods of Use |
| WO2002046472A2 (en) * | 2000-12-08 | 2002-06-13 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US20030211488A1 (en) * | 2002-05-07 | 2003-11-13 | Northwestern University | Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection |
| CN101198707A (en) * | 2004-05-12 | 2008-06-11 | 内诺斯佩尔公司 | Bio-barcode based detection of target analytes |
| US8252756B2 (en) * | 2005-06-14 | 2012-08-28 | Northwestern University | Nucleic acid functionalized nanoparticles for therapeutic applications |
| EP2084279A4 (en) * | 2006-10-04 | 2011-07-06 | Brookhaven Science Ass Llc | Dna-guided nanoparticle assemblies |
| CA2711151A1 (en) * | 2008-01-03 | 2009-09-24 | University Of Central Florida Research Foundation, Inc. | Detection of analytes using metal nanoparticle probes and dynamic light scattering |
| US20120107242A1 (en) * | 2010-09-30 | 2012-05-03 | The Board Of Trustees Of The University Of Illinois | Nucleic acid-mediated shape control of nanoparticles for biomedical applications |
| CN104919054A (en) * | 2012-07-31 | 2015-09-16 | 胡安·卡洛斯·海梅 | Method for obtaining and detecting a marker of objects to be identified, related marker, authentication method and verification method |
| CN103007294A (en) * | 2012-12-28 | 2013-04-03 | 中国科学院上海应用物理研究所 | Multivalent immunostimulation nanoformula, preparation method and application thereof |
| CN104263837B (en) * | 2014-10-13 | 2016-03-23 | 江南大学 | The trimerical surface enhanced Raman scattering effect of golden nanometer particle modified based on triple beacon detects Hg in the aqueous solution 2+and/or Ag +method |
| US20180172678A1 (en) * | 2016-12-16 | 2018-06-21 | Agency For Science, Technology And Research | Dynamic Light Scattering Nanoplatform For High-Throughput Drug Screening |
| CN109517880B (en) * | 2018-11-15 | 2022-05-17 | 中山大学 | Method for detecting telomerase activity based on strand displacement reaction and DNA modified gold nanoparticles |
| CN111118116B (en) * | 2019-09-11 | 2023-04-25 | 济南国科医工科技发展有限公司 | Multiple miRNA detection method based on gold nanoparticle aggregation and dispersion |
| CN111235228B (en) * | 2020-01-22 | 2023-04-14 | 中山大学 | Method for detecting CA125 based on polymerase chain reaction and dynamic light scattering |
-
2020
- 2020-11-12 CN CN202011264226.4A patent/CN112698020B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102507551A (en) * | 2011-10-24 | 2012-06-20 | 国家纳米科学中心 | Reagents for detecting AChE (acetylcholinesterase) and preparation method thereof |
| CN103540651A (en) * | 2012-07-12 | 2014-01-29 | 中国科学院上海应用物理研究所 | Nanometer gold complex as well as preparation and application thereof |
| CN105334176A (en) * | 2015-11-30 | 2016-02-17 | 天津脉络生物科技有限公司 | Composition for AChE, method for screening AChE inhibitor and application |
| CN108359715A (en) * | 2018-02-06 | 2018-08-03 | 中国科学院上海高等研究院 | The controllable Nano-Au probe and its preparation and application that Poly A are mediated |
| CN108841923A (en) * | 2018-06-07 | 2018-11-20 | 南京邮电大学 | A kind of quantum dot based on DSN enzyme-magnetic bead miRNA sensor and preparation method thereof and detection method |
| CN109724970A (en) * | 2019-01-31 | 2019-05-07 | 华侨大学 | A method of based on gold nanoparticle colorimetric detection mercury ion |
| CN110530847A (en) * | 2019-09-26 | 2019-12-03 | 辽宁大学 | A kind of specific detection Cu2+Raman spectrum base and its preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112698020A (en) | 2021-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Analytical methods based on the light-scattering of plasmonic nanoparticles at the single particle level with dark-field microscopy imaging | |
| Li et al. | Characterization and noninvasive diagnosis of bladder cancer with serum surface enhanced Raman spectroscopy and genetic algorithms | |
| Zhou et al. | Machine learning-augmented surface-enhanced spectroscopy toward next-generation molecular diagnostics | |
| Dos Santos et al. | Unraveling surface-enhanced Raman spectroscopy results through chemometrics and machine learning: Principles, progress, and trends | |
| CN106053429B (en) | Urine modified nucleoside determination method based on surface enhanced resonance raman spectra | |
| Yang et al. | Machine learning-assisted optical nano-sensor arrays in microorganism analysis | |
| WO2019140305A1 (en) | Spectroscopic biological material characterization | |
| Kastanos et al. | A novel method for bacterial UTI diagnosis using Raman spectroscopy | |
| Știufiuc et al. | Solid plasmonic substrates for breast cancer detection by means of SERS analysis of blood plasma | |
| Li et al. | New application of old methods: Development of colorimetric sensor array based on Tollen’s reagent for the discrimination of aldehydes based on Tollen’s reagent | |
| CN112698020B (en) | Multimodal coupling analysis method of cross response system based on DNA-AuNP coding | |
| Fang et al. | Fast discrimination of tumor and blood cells by label-free surface-enhanced Raman scattering spectra and deep learning | |
| Orságová Králová et al. | Electrochemically deposited silver detection substrate for surface-enhanced Raman spectroscopy cancer diagnostics | |
| Fu et al. | Rapid identification of the resistance of urinary tract pathogenic bacteria using deep learning–based spectroscopic analysis | |
| Shariati-Rad et al. | Carbon dot-based colorimetric sensor array for the discrimination of different water samples | |
| Ciobanu et al. | Potential of Raman spectroscopy for blood-based biopsy | |
| Teng et al. | Pathological identification of brain tumors based on the characteristics of molecular fragments generated by laser ablation combined with a spiking neural network | |
| Zhu et al. | Preparation of a multifunctional and ultrasensitive Au@ AgNPs-Van/PDMS film SERS substrate for rapid detection of foodborne pathogens in beef | |
| CN115420726A (en) | Method for rapidly identifying target object by using reconstructed SERS spectrum | |
| Zhang et al. | Advances of machine learning-assisted small extracellular vesicles detection strategy | |
| Masoomi et al. | An optical-nose device based on fluorescent nanomaterials sensor array for authentication of saffron | |
| Zhang et al. | Detection of aldehydes by gold nanoparticle colorimetric array based on Tollens' reagent | |
| Lin et al. | Multivariate approaches for SERS data analysis in clinical applications | |
| CN114878543A (en) | Raman spectrum detection and identification method and system for trace substance | |
| CN113640266A (en) | Detection method for storing and releasing iron in cells by ferritin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |